nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylic acid—Niacin—atherosclerosis	0.521	1	CrCtD
Salicylic acid—PTGS2—atherosclerosis	0.0625	0.529	CbGaD
Salicylic acid—ALB—atherosclerosis	0.0557	0.471	CbGaD
Salicylic acid—SLC16A1—Niacin—atherosclerosis	0.0534	0.187	CbGbCtD
Salicylic acid—SLC16A1—Pravastatin—atherosclerosis	0.0413	0.145	CbGbCtD
Salicylic acid—SLCO2B1—Niacin—atherosclerosis	0.0336	0.118	CbGbCtD
Salicylic acid—SLCO2B1—Rosuvastatin—atherosclerosis	0.0286	0.0999	CbGbCtD
Salicylic acid—SLCO2B1—Pravastatin—atherosclerosis	0.026	0.0909	CbGbCtD
Salicylic acid—SLC22A11—Pravastatin—atherosclerosis	0.0213	0.0746	CbGbCtD
Salicylic acid—SLC22A7—Pravastatin—atherosclerosis	0.0203	0.0711	CbGbCtD
Salicylic acid—SLC22A8—Pravastatin—atherosclerosis	0.0124	0.0434	CbGbCtD
Salicylic acid—SLC22A6—Pravastatin—atherosclerosis	0.00864	0.0302	CbGbCtD
Salicylic acid—ALB—Rosuvastatin—atherosclerosis	0.00809	0.0283	CbGbCtD
Salicylic acid—CYP2C9—Rosuvastatin—atherosclerosis	0.00436	0.0153	CbGbCtD
Salicylic acid—ABCB1—Ezetimibe—atherosclerosis	0.00423	0.0148	CbGbCtD
Salicylic acid—CYP2C9—Simvastatin—atherosclerosis	0.00405	0.0142	CbGbCtD
Salicylic acid—CYP2C9—Lovastatin—atherosclerosis	0.00397	0.0139	CbGbCtD
Salicylic acid—CYP2C9—Pravastatin—atherosclerosis	0.00397	0.0139	CbGbCtD
Salicylic acid—ABCB1—Simvastatin—atherosclerosis	0.00393	0.0138	CbGbCtD
Salicylic acid—ABCB1—Lovastatin—atherosclerosis	0.00385	0.0135	CbGbCtD
Salicylic acid—ABCB1—Pravastatin—atherosclerosis	0.00385	0.0135	CbGbCtD
Salicylic acid—SLC22A10—liver—atherosclerosis	0.000988	0.173	CbGeAlD
Salicylic acid—Upset stomach—Lovastatin—atherosclerosis	0.000915	0.0349	CcSEcCtD
Salicylic acid—Upset stomach—Simvastatin—atherosclerosis	0.000855	0.0327	CcSEcCtD
Salicylic acid—Heartburn—Niacin—atherosclerosis	0.000748	0.0286	CcSEcCtD
Salicylic acid—Burning sensation—Niacin—atherosclerosis	0.000741	0.0283	CcSEcCtD
Salicylic acid—Heartburn—Pravastatin—atherosclerosis	0.000736	0.0281	CcSEcCtD
Salicylic acid—Hearing impaired—Pravastatin—atherosclerosis	0.000532	0.0203	CcSEcCtD
Salicylic acid—Skin exfoliation—Niacin—atherosclerosis	0.000491	0.0188	CcSEcCtD
Salicylic acid—Oesophagitis—Niacin—atherosclerosis	0.00047	0.018	CcSEcCtD
Salicylic acid—PTGS2—leg—atherosclerosis	0.000454	0.0793	CbGeAlD
Salicylic acid—Deafness—Pravastatin—atherosclerosis	0.000411	0.0157	CcSEcCtD
Salicylic acid—PTGS2—hindlimb—atherosclerosis	0.000405	0.0708	CbGeAlD
Salicylic acid—Abdominal discomfort—Lovastatin—atherosclerosis	0.00036	0.0138	CcSEcCtD
Salicylic acid—Hepatitis—Rosuvastatin—atherosclerosis	0.000355	0.0136	CcSEcCtD
Salicylic acid—PTGS2—appendage—atherosclerosis	0.000348	0.0607	CbGeAlD
Salicylic acid—Abdominal discomfort—Simvastatin—atherosclerosis	0.000337	0.0129	CcSEcCtD
Salicylic acid—Hepatitis—Lovastatin—atherosclerosis	0.000301	0.0115	CcSEcCtD
Salicylic acid—Hepatitis—Ezetimibe—atherosclerosis	0.000295	0.0113	CcSEcCtD
Salicylic acid—Weight increased—Pravastatin—atherosclerosis	0.000289	0.0111	CcSEcCtD
Salicylic acid—Erythema multiforme—Lovastatin—atherosclerosis	0.000285	0.0109	CcSEcCtD
Salicylic acid—Hepatitis—Simvastatin—atherosclerosis	0.000281	0.0108	CcSEcCtD
Salicylic acid—Erythema multiforme—Ezetimibe—atherosclerosis	0.000279	0.0107	CcSEcCtD
Salicylic acid—Aminosalicylic Acid—ALOX5—atherosclerosis	0.000268	0.127	CrCbGaD
Salicylic acid—Erythema multiforme—Simvastatin—atherosclerosis	0.000266	0.0102	CcSEcCtD
Salicylic acid—PTGS1—artery—atherosclerosis	0.00026	0.0454	CbGeAlD
Salicylic acid—Hepatitis—Niacin—atherosclerosis	0.000258	0.00987	CcSEcCtD
Salicylic acid—Erythema—Ezetimibe—atherosclerosis	0.000257	0.00982	CcSEcCtD
Salicylic acid—Dysgeusia—Lovastatin—atherosclerosis	0.000257	0.0098	CcSEcCtD
Salicylic acid—Hepatitis—Pravastatin—atherosclerosis	0.000254	0.00972	CcSEcCtD
Salicylic acid—Confusional state—Rosuvastatin—atherosclerosis	0.000254	0.00972	CcSEcCtD
Salicylic acid—PTGS2—artery—atherosclerosis	0.000248	0.0434	CbGeAlD
Salicylic acid—Acetylsalicylic acid—EDNRA—atherosclerosis	0.000247	0.117	CrCbGaD
Salicylic acid—Erythema—Simvastatin—atherosclerosis	0.000245	0.00936	CcSEcCtD
Salicylic acid—Tinnitus—Niacin—atherosclerosis	0.000241	0.00921	CcSEcCtD
Salicylic acid—Erythema multiforme—Pravastatin—atherosclerosis	0.000241	0.00919	CcSEcCtD
Salicylic acid—Dysgeusia—Simvastatin—atherosclerosis	0.00024	0.00917	CcSEcCtD
Salicylic acid—Meclofenamic acid—ALOX5—atherosclerosis	0.000239	0.113	CrCbGaD
Salicylic acid—Tinnitus—Pravastatin—atherosclerosis	0.000237	0.00906	CcSEcCtD
Salicylic acid—Erythema—Niacin—atherosclerosis	0.000225	0.0086	CcSEcCtD
Salicylic acid—Dyspepsia—Rosuvastatin—atherosclerosis	0.000222	0.00848	CcSEcCtD
Salicylic acid—PTGS1—endothelium—atherosclerosis	0.00022	0.0384	CbGeAlD
Salicylic acid—Dysgeusia—Pravastatin—atherosclerosis	0.000217	0.00829	CcSEcCtD
Salicylic acid—Constipation—Rosuvastatin—atherosclerosis	0.000216	0.00824	CcSEcCtD
Salicylic acid—Pain—Rosuvastatin—atherosclerosis	0.000216	0.00824	CcSEcCtD
Salicylic acid—Confusional state—Lovastatin—atherosclerosis	0.000216	0.00824	CcSEcCtD
Salicylic acid—Confusional state—Ezetimibe—atherosclerosis	0.000211	0.00808	CcSEcCtD
Salicylic acid—Mesalazine—ALOX5—atherosclerosis	0.00021	0.0999	CrCbGaD
Salicylic acid—PTGS2—endothelium—atherosclerosis	0.00021	0.0367	CbGeAlD
Salicylic acid—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000208	0.00794	CcSEcCtD
Salicylic acid—Anorexia—Lovastatin—atherosclerosis	0.000204	0.00779	CcSEcCtD
Salicylic acid—PTGS1—blood vessel—atherosclerosis	0.000202	0.0354	CbGeAlD
Salicylic acid—Confusional state—Simvastatin—atherosclerosis	0.000202	0.0077	CcSEcCtD
Salicylic acid—SLC16A1—cardiovascular system—atherosclerosis	0.000201	0.0352	CbGeAlD
Salicylic acid—Urticaria—Rosuvastatin—atherosclerosis	0.0002	0.00766	CcSEcCtD
Salicylic acid—Oedema—Simvastatin—atherosclerosis	0.0002	0.00764	CcSEcCtD
Salicylic acid—PTGS2—blood vessel—atherosclerosis	0.000194	0.0338	CbGeAlD
Salicylic acid—Anorexia—Simvastatin—atherosclerosis	0.000191	0.00728	CcSEcCtD
Salicylic acid—Dyspepsia—Lovastatin—atherosclerosis	0.000188	0.00719	CcSEcCtD
Salicylic acid—Decreased appetite—Lovastatin—atherosclerosis	0.000186	0.0071	CcSEcCtD
Salicylic acid—Dyspepsia—Ezetimibe—atherosclerosis	0.000185	0.00705	CcSEcCtD
Salicylic acid—Oedema—Niacin—atherosclerosis	0.000184	0.00701	CcSEcCtD
Salicylic acid—Pain—Lovastatin—atherosclerosis	0.000183	0.00698	CcSEcCtD
Salicylic acid—Constipation—Lovastatin—atherosclerosis	0.000183	0.00698	CcSEcCtD
Salicylic acid—Confusional state—Pravastatin—atherosclerosis	0.000182	0.00696	CcSEcCtD
Salicylic acid—Decreased appetite—Ezetimibe—atherosclerosis	0.000182	0.00696	CcSEcCtD
Salicylic acid—Oedema—Pravastatin—atherosclerosis	0.000181	0.00691	CcSEcCtD
Salicylic acid—Pain—Ezetimibe—atherosclerosis	0.000179	0.00685	CcSEcCtD
Salicylic acid—Constipation—Ezetimibe—atherosclerosis	0.000179	0.00685	CcSEcCtD
Salicylic acid—Pruritus—Rosuvastatin—atherosclerosis	0.000178	0.00682	CcSEcCtD
Salicylic acid—SLC16A1—adipose tissue—atherosclerosis	0.000178	0.031	CbGeAlD
Salicylic acid—Feeling abnormal—Lovastatin—atherosclerosis	0.000176	0.00673	CcSEcCtD
Salicylic acid—Dyspepsia—Simvastatin—atherosclerosis	0.000176	0.00672	CcSEcCtD
Salicylic acid—Anorexia—Niacin—atherosclerosis	0.000175	0.00669	CcSEcCtD
Salicylic acid—Decreased appetite—Simvastatin—atherosclerosis	0.000174	0.00664	CcSEcCtD
Salicylic acid—Aminosalicylic Acid—MPO—atherosclerosis	0.000173	0.082	CrCbGaD
Salicylic acid—Feeling abnormal—Ezetimibe—atherosclerosis	0.000173	0.0066	CcSEcCtD
Salicylic acid—Diarrhoea—Rosuvastatin—atherosclerosis	0.000173	0.00659	CcSEcCtD
Salicylic acid—Anorexia—Pravastatin—atherosclerosis	0.000172	0.00658	CcSEcCtD
Salicylic acid—Constipation—Simvastatin—atherosclerosis	0.000171	0.00653	CcSEcCtD
Salicylic acid—Pain—Simvastatin—atherosclerosis	0.000171	0.00653	CcSEcCtD
Salicylic acid—Urticaria—Lovastatin—atherosclerosis	0.00017	0.00649	CcSEcCtD
Salicylic acid—SLC22A11—liver—atherosclerosis	0.000167	0.0292	CbGeAlD
Salicylic acid—Dizziness—Rosuvastatin—atherosclerosis	0.000167	0.00637	CcSEcCtD
Salicylic acid—Urticaria—Ezetimibe—atherosclerosis	0.000167	0.00636	CcSEcCtD
Salicylic acid—Feeling abnormal—Simvastatin—atherosclerosis	0.000165	0.0063	CcSEcCtD
Salicylic acid—Somnolence—Niacin—atherosclerosis	0.000163	0.00624	CcSEcCtD
Salicylic acid—SLC22A7—liver—atherosclerosis	0.000163	0.0285	CbGeAlD
Salicylic acid—Dyspepsia—Niacin—atherosclerosis	0.000162	0.00617	CcSEcCtD
Salicylic acid—Decreased appetite—Niacin—atherosclerosis	0.00016	0.0061	CcSEcCtD
Salicylic acid—Dyspepsia—Pravastatin—atherosclerosis	0.000159	0.00608	CcSEcCtD
Salicylic acid—Rash—Rosuvastatin—atherosclerosis	0.000159	0.00608	CcSEcCtD
Salicylic acid—Dermatitis—Rosuvastatin—atherosclerosis	0.000159	0.00607	CcSEcCtD
Salicylic acid—Urticaria—Simvastatin—atherosclerosis	0.000159	0.00607	CcSEcCtD
Salicylic acid—Headache—Rosuvastatin—atherosclerosis	0.000158	0.00604	CcSEcCtD
Salicylic acid—Decreased appetite—Pravastatin—atherosclerosis	0.000157	0.006	CcSEcCtD
Salicylic acid—Pain—Niacin—atherosclerosis	0.000157	0.006	CcSEcCtD
Salicylic acid—Pain—Pravastatin—atherosclerosis	0.000155	0.00591	CcSEcCtD
Salicylic acid—Constipation—Pravastatin—atherosclerosis	0.000155	0.00591	CcSEcCtD
Salicylic acid—SLCO2B1—adipose tissue—atherosclerosis	0.000153	0.0267	CbGeAlD
Salicylic acid—Pruritus—Lovastatin—atherosclerosis	0.000151	0.00578	CcSEcCtD
Salicylic acid—Nausea—Rosuvastatin—atherosclerosis	0.00015	0.00572	CcSEcCtD
Salicylic acid—Feeling abnormal—Pravastatin—atherosclerosis	0.000149	0.00569	CcSEcCtD
Salicylic acid—Pruritus—Ezetimibe—atherosclerosis	0.000148	0.00567	CcSEcCtD
Salicylic acid—Diarrhoea—Lovastatin—atherosclerosis	0.000146	0.00559	CcSEcCtD
Salicylic acid—Urticaria—Niacin—atherosclerosis	0.000146	0.00557	CcSEcCtD
Salicylic acid—Urticaria—Pravastatin—atherosclerosis	0.000144	0.00549	CcSEcCtD
Salicylic acid—Diarrhoea—Ezetimibe—atherosclerosis	0.000143	0.00548	CcSEcCtD
Salicylic acid—Pruritus—Simvastatin—atherosclerosis	0.000141	0.0054	CcSEcCtD
Salicylic acid—Dizziness—Lovastatin—atherosclerosis	0.000141	0.0054	CcSEcCtD
Salicylic acid—Dizziness—Ezetimibe—atherosclerosis	0.000139	0.0053	CcSEcCtD
Salicylic acid—Diarrhoea—Simvastatin—atherosclerosis	0.000137	0.00523	CcSEcCtD
Salicylic acid—Vomiting—Lovastatin—atherosclerosis	0.000136	0.00519	CcSEcCtD
Salicylic acid—Mesalazine—MPO—atherosclerosis	0.000136	0.0644	CrCbGaD
Salicylic acid—Rash—Lovastatin—atherosclerosis	0.000135	0.00515	CcSEcCtD
Salicylic acid—Dermatitis—Lovastatin—atherosclerosis	0.000135	0.00514	CcSEcCtD
Salicylic acid—Headache—Lovastatin—atherosclerosis	0.000134	0.00512	CcSEcCtD
Salicylic acid—Vomiting—Ezetimibe—atherosclerosis	0.000133	0.00509	CcSEcCtD
Salicylic acid—Dizziness—Simvastatin—atherosclerosis	0.000132	0.00505	CcSEcCtD
Salicylic acid—Rash—Ezetimibe—atherosclerosis	0.000132	0.00505	CcSEcCtD
Salicylic acid—Dermatitis—Ezetimibe—atherosclerosis	0.000132	0.00505	CcSEcCtD
Salicylic acid—Headache—Ezetimibe—atherosclerosis	0.000131	0.00502	CcSEcCtD
Salicylic acid—Pruritus—Niacin—atherosclerosis	0.00013	0.00496	CcSEcCtD
Salicylic acid—Pruritus—Pravastatin—atherosclerosis	0.000128	0.00489	CcSEcCtD
Salicylic acid—Vomiting—Simvastatin—atherosclerosis	0.000127	0.00486	CcSEcCtD
Salicylic acid—Nausea—Lovastatin—atherosclerosis	0.000127	0.00485	CcSEcCtD
Salicylic acid—Rash—Simvastatin—atherosclerosis	0.000126	0.00482	CcSEcCtD
Salicylic acid—Dermatitis—Simvastatin—atherosclerosis	0.000126	0.00481	CcSEcCtD
Salicylic acid—Diarrhoea—Niacin—atherosclerosis	0.000126	0.0048	CcSEcCtD
Salicylic acid—Headache—Simvastatin—atherosclerosis	0.000125	0.00479	CcSEcCtD
Salicylic acid—Nausea—Ezetimibe—atherosclerosis	0.000125	0.00476	CcSEcCtD
Salicylic acid—SLC16A1—liver—atherosclerosis	0.000125	0.0218	CbGeAlD
Salicylic acid—Diarrhoea—Pravastatin—atherosclerosis	0.000124	0.00473	CcSEcCtD
Salicylic acid—Dizziness—Niacin—atherosclerosis	0.000121	0.00464	CcSEcCtD
Salicylic acid—Mesalazine—PPARG—atherosclerosis	0.00012	0.0571	CrCbGaD
Salicylic acid—ABCB1—blood vessel—atherosclerosis	0.00012	0.0209	CbGeAlD
Salicylic acid—Dizziness—Pravastatin—atherosclerosis	0.00012	0.00457	CcSEcCtD
Salicylic acid—Nausea—Simvastatin—atherosclerosis	0.000119	0.00454	CcSEcCtD
Salicylic acid—Vomiting—Niacin—atherosclerosis	0.000117	0.00446	CcSEcCtD
Salicylic acid—Rash—Niacin—atherosclerosis	0.000116	0.00442	CcSEcCtD
Salicylic acid—Dermatitis—Niacin—atherosclerosis	0.000116	0.00442	CcSEcCtD
Salicylic acid—Headache—Niacin—atherosclerosis	0.000115	0.00439	CcSEcCtD
Salicylic acid—Vomiting—Pravastatin—atherosclerosis	0.000115	0.00439	CcSEcCtD
Salicylic acid—Rash—Pravastatin—atherosclerosis	0.000114	0.00435	CcSEcCtD
Salicylic acid—Dermatitis—Pravastatin—atherosclerosis	0.000114	0.00435	CcSEcCtD
Salicylic acid—Headache—Pravastatin—atherosclerosis	0.000113	0.00433	CcSEcCtD
Salicylic acid—Nausea—Niacin—atherosclerosis	0.000109	0.00417	CcSEcCtD
Salicylic acid—Nausea—Pravastatin—atherosclerosis	0.000107	0.0041	CcSEcCtD
Salicylic acid—SLCO2B1—liver—atherosclerosis	0.000107	0.0187	CbGeAlD
Salicylic acid—PTGS1—connective tissue—atherosclerosis	0.000104	0.0181	CbGeAlD
Salicylic acid—Salicylate-sodium—PTGS2—atherosclerosis	0.000101	0.0477	CrCbGaD
Salicylic acid—PTGS2—connective tissue—atherosclerosis	9.92e-05	0.0173	CbGeAlD
Salicylic acid—CYP2C9—cardiovascular system—atherosclerosis	9.89e-05	0.0173	CbGeAlD
Salicylic acid—ALB—liver—atherosclerosis	9.8e-05	0.0171	CbGeAlD
Salicylic acid—PTGS1—cardiovascular system—atherosclerosis	9.03e-05	0.0158	CbGeAlD
Salicylic acid—PTGS2—cardiovascular system—atherosclerosis	8.63e-05	0.0151	CbGeAlD
Salicylic acid—PTGS1—adipose tissue—atherosclerosis	7.97e-05	0.0139	CbGeAlD
Salicylic acid—PTGS2—adipose tissue—atherosclerosis	7.61e-05	0.0133	CbGeAlD
Salicylic acid—Magnesium salicylate—PTGS2—atherosclerosis	6.89e-05	0.0327	CrCbGaD
Salicylic acid—Aminosalicylic Acid—PTGS2—atherosclerosis	6.48e-05	0.0307	CrCbGaD
Salicylic acid—Diflunisal—PTGS2—atherosclerosis	6.48e-05	0.0307	CrCbGaD
Salicylic acid—Magnesium salicylate—ALB—atherosclerosis	6.14e-05	0.0291	CrCbGaD
Salicylic acid—CYP2C9—liver—atherosclerosis	6.12e-05	0.0107	CbGeAlD
Salicylic acid—Salsalate—PTGS2—atherosclerosis	5.86e-05	0.0278	CrCbGaD
Salicylic acid—Meclofenamic acid—PTGS2—atherosclerosis	5.77e-05	0.0274	CrCbGaD
Salicylic acid—Diflunisal—ALB—atherosclerosis	5.77e-05	0.0274	CrCbGaD
Salicylic acid—ABCB1—cardiovascular system—atherosclerosis	5.34e-05	0.00933	CbGeAlD
Salicylic acid—PTGS2—liver—atherosclerosis	5.34e-05	0.00933	CbGeAlD
Salicylic acid—Mesalazine—PTGS2—atherosclerosis	5.08e-05	0.0241	CrCbGaD
Salicylic acid—ABCB1—adipose tissue—atherosclerosis	4.71e-05	0.00823	CbGeAlD
Salicylic acid—Mefenamic acid—PTGS2—atherosclerosis	4.49e-05	0.0213	CrCbGaD
Salicylic acid—Acetylsalicylic acid—PTGS2—atherosclerosis	4.38e-05	0.0208	CrCbGaD
Salicylic acid—Acetylsalicylic acid—ALB—atherosclerosis	3.9e-05	0.0185	CrCbGaD
Salicylic acid—ABCB1—liver—atherosclerosis	3.3e-05	0.00577	CbGeAlD
Salicylic acid—ALB—Metabolism—PLA2G2A—atherosclerosis	4.24e-06	0.000102	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYP7A1—atherosclerosis	4.24e-06	0.000102	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PDGFB—atherosclerosis	4.24e-06	0.000102	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—MMP1—atherosclerosis	4.19e-06	0.000101	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ABCG5—atherosclerosis	4.19e-06	0.000101	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	4.19e-06	0.000101	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	4.18e-06	0.000101	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—INS—atherosclerosis	4.17e-06	0.000101	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—AKT1—atherosclerosis	4.14e-06	0.0001	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CYBA—atherosclerosis	4.12e-06	9.96e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.12e-06	9.95e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—FABP4—atherosclerosis	4.11e-06	9.93e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—LCAT—atherosclerosis	4.11e-06	9.93e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—LPA—atherosclerosis	4.05e-06	9.78e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PARP1—atherosclerosis	4.04e-06	9.75e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—APOA4—atherosclerosis	4.04e-06	9.74e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—CAV1—atherosclerosis	4.02e-06	9.71e-05	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	4.02e-06	9.71e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	4.02e-06	9.69e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—APOA1—atherosclerosis	4.01e-06	9.69e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—NAMPT—atherosclerosis	4e-06	9.66e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.98e-06	9.6e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—LIPC—atherosclerosis	3.98e-06	9.6e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYP7A1—atherosclerosis	3.97e-06	9.57e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	3.96e-06	9.56e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—APOC3—atherosclerosis	3.95e-06	9.54e-05	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—VEGFA—atherosclerosis	3.95e-06	9.53e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.94e-06	9.52e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—LDLR—atherosclerosis	3.93e-06	9.48e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYP27A1—atherosclerosis	3.92e-06	9.47e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—BGN—atherosclerosis	3.92e-06	9.47e-05	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—STAT3—atherosclerosis	3.91e-06	9.44e-05	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	3.9e-06	9.42e-05	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—IL6—atherosclerosis	3.9e-06	9.41e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ABCA1—atherosclerosis	3.9e-06	9.4e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.89e-06	9.4e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—APOA5—atherosclerosis	3.88e-06	9.37e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	3.85e-06	9.29e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	3.84e-06	9.27e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CETP—atherosclerosis	3.84e-06	9.26e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—F2—atherosclerosis	3.83e-06	9.24e-05	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—ALB—atherosclerosis	3.82e-06	9.22e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—NOS2—atherosclerosis	3.78e-06	9.13e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	3.78e-06	9.12e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.77e-06	9.1e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	3.77e-06	9.09e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PLA2G1B—atherosclerosis	3.74e-06	9.02e-05	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MAPK3—atherosclerosis	3.73e-06	9.02e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PLA2G2A—atherosclerosis	3.72e-06	8.98e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—APOA2—atherosclerosis	3.72e-06	8.98e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ALOX5AP—atherosclerosis	3.72e-06	8.98e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ALOX15—atherosclerosis	3.72e-06	8.98e-05	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.7e-06	8.94e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.69e-06	8.92e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—SCARB1—atherosclerosis	3.67e-06	8.87e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ABCG5—atherosclerosis	3.67e-06	8.87e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYP27A1—atherosclerosis	3.67e-06	8.85e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PIK3CG—atherosclerosis	3.66e-06	8.84e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3.66e-06	8.84e-05	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—NOS3—atherosclerosis	3.65e-06	8.82e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3.65e-06	8.82e-05	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—TGFB1—atherosclerosis	3.62e-06	8.75e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ALOX5—atherosclerosis	3.61e-06	8.71e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	3.61e-06	8.71e-05	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—AKT1—atherosclerosis	3.6e-06	8.68e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	3.59e-06	8.66e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.58e-06	8.64e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—LPA—atherosclerosis	3.55e-06	8.57e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	3.52e-06	8.5e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—APOA2—atherosclerosis	3.47e-06	8.39e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	3.47e-06	8.39e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	3.47e-06	8.39e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ALOX15—atherosclerosis	3.47e-06	8.39e-05	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.47e-06	8.38e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—HMGCR—atherosclerosis	3.47e-06	8.38e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—BGN—atherosclerosis	3.44e-06	8.3e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ABCG5—atherosclerosis	3.43e-06	8.29e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	3.43e-06	8.28e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—APOA5—atherosclerosis	3.4e-06	8.21e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—IGF1—atherosclerosis	3.35e-06	8.1e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—HMOX1—atherosclerosis	3.34e-06	8.07e-05	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PTGS2—atherosclerosis	3.34e-06	8.07e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.33e-06	8.05e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—LPA—atherosclerosis	3.31e-06	8e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PLA2G1B—atherosclerosis	3.27e-06	7.9e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.24e-06	7.83e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—NAMPT—atherosclerosis	3.24e-06	7.82e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.22e-06	7.77e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—LIPC—atherosclerosis	3.22e-06	7.77e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—BGN—atherosclerosis	3.21e-06	7.75e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—APOB—atherosclerosis	3.2e-06	7.73e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—APOC3—atherosclerosis	3.2e-06	7.72e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.19e-06	7.69e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—SERPINE1—atherosclerosis	3.18e-06	7.69e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—APOA5—atherosclerosis	3.18e-06	7.67e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—LDLR—atherosclerosis	3.18e-06	7.67e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ALOX5—atherosclerosis	3.16e-06	7.63e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GSTM1—atherosclerosis	3.11e-06	7.52e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CETP—atherosclerosis	3.1e-06	7.49e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ABCA1—atherosclerosis	3.09e-06	7.47e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.09e-06	7.45e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	3.06e-06	7.38e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—LPL—atherosclerosis	3.06e-06	7.38e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.04e-06	7.35e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—NOS3—atherosclerosis	3.04e-06	7.34e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—APOB—atherosclerosis	3.03e-06	7.33e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.02e-06	7.3e-05	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—AKT1—atherosclerosis	3.01e-06	7.27e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3e-06	7.23e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.99e-06	7.22e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GPX1—atherosclerosis	2.98e-06	7.2e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—SCARB1—atherosclerosis	2.97e-06	7.18e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ALOX5—atherosclerosis	2.95e-06	7.13e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CD36—atherosclerosis	2.9e-06	7.01e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—LPL—atherosclerosis	2.9e-06	6.99e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—NAMPT—atherosclerosis	2.84e-06	6.85e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—LIPC—atherosclerosis	2.82e-06	6.8e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PRKCG—atherosclerosis	2.82e-06	6.8e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—HMGCR—atherosclerosis	2.81e-06	6.78e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—APOC3—atherosclerosis	2.8e-06	6.76e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—LDLR—atherosclerosis	2.78e-06	6.72e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—MTHFR—atherosclerosis	2.75e-06	6.64e-05	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IL6—atherosclerosis	2.73e-06	6.59e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.73e-06	6.59e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CETP—atherosclerosis	2.72e-06	6.57e-05	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	2.71e-06	6.55e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PPARA—atherosclerosis	2.7e-06	6.52e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	2.67e-06	6.45e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—HMOX1—atherosclerosis	2.65e-06	6.4e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—NAMPT—atherosclerosis	2.65e-06	6.4e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.63e-06	6.36e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—LIPC—atherosclerosis	2.63e-06	6.36e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—APOC3—atherosclerosis	2.62e-06	6.32e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—AGT—atherosclerosis	2.61e-06	6.31e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MTHFR—atherosclerosis	2.61e-06	6.3e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—SCARB1—atherosclerosis	2.6e-06	6.29e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—LDLR—atherosclerosis	2.6e-06	6.28e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—APOE—atherosclerosis	2.56e-06	6.19e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—APOB—atherosclerosis	2.54e-06	6.13e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CETP—atherosclerosis	2.54e-06	6.13e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PDGFB—atherosclerosis	2.54e-06	6.13e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CAV1—atherosclerosis	2.54e-06	6.13e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—APOA1—atherosclerosis	2.53e-06	6.11e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.53e-06	6.11e-05	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—AKT1—atherosclerosis	2.52e-06	6.08e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ABCA1—atherosclerosis	2.5e-06	6.04e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GSTM1—atherosclerosis	2.47e-06	5.97e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—HMGCR—atherosclerosis	2.46e-06	5.94e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—SCARB1—atherosclerosis	2.43e-06	5.87e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—APOE—atherosclerosis	2.43e-06	5.86e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—LPL—atherosclerosis	2.43e-06	5.86e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	2.41e-06	5.82e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CAV1—atherosclerosis	2.41e-06	5.81e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—APOA1—atherosclerosis	2.4e-06	5.8e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.37e-06	5.72e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GPX1—atherosclerosis	2.37e-06	5.72e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PIK3CG—atherosclerosis	2.31e-06	5.58e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CD36—atherosclerosis	2.31e-06	5.57e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—HMGCR—atherosclerosis	2.3e-06	5.55e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—NOS2—atherosclerosis	2.26e-06	5.46e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PPARG—atherosclerosis	2.23e-06	5.39e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ABCA1—atherosclerosis	2.19e-06	5.29e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—VEGFA—atherosclerosis	2.19e-06	5.29e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—INS—atherosclerosis	2.19e-06	5.28e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—MTHFR—atherosclerosis	2.18e-06	5.27e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—HMOX1—atherosclerosis	2.15e-06	5.18e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PPARA—atherosclerosis	2.14e-06	5.17e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—AGT—atherosclerosis	2.08e-06	5.01e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—INS—atherosclerosis	2.07e-06	5.01e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.07e-06	5e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—MAPK3—atherosclerosis	2.07e-06	5e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—APOB—atherosclerosis	2.06e-06	4.96e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ABCA1—atherosclerosis	2.05e-06	4.94e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—APOE—atherosclerosis	2.03e-06	4.91e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CAV1—atherosclerosis	2.02e-06	4.87e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—APOA1—atherosclerosis	2.01e-06	4.85e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—TGFB1—atherosclerosis	2.01e-06	4.85e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ALB—atherosclerosis	2.01e-06	4.84e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GSTM1—atherosclerosis	2e-06	4.83e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—LPL—atherosclerosis	1.96e-06	4.74e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—NOS3—atherosclerosis	1.92e-06	4.63e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GPX1—atherosclerosis	1.92e-06	4.62e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—SERPINE1—atherosclerosis	1.91e-06	4.6e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—HMOX1—atherosclerosis	1.88e-06	4.54e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CD36—atherosclerosis	1.87e-06	4.5e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PIK3CG—atherosclerosis	1.84e-06	4.43e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—NOS3—atherosclerosis	1.82e-06	4.39e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—APOB—atherosclerosis	1.8e-06	4.35e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PPARG—atherosclerosis	1.77e-06	4.28e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—MTHFR—atherosclerosis	1.77e-06	4.27e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—HMOX1—atherosclerosis	1.76e-06	4.24e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PTGS2—atherosclerosis	1.76e-06	4.24e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GSTM1—atherosclerosis	1.75e-06	4.23e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—INS—atherosclerosis	1.74e-06	4.19e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PPARA—atherosclerosis	1.73e-06	4.19e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—LPL—atherosclerosis	1.72e-06	4.15e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—APOB—atherosclerosis	1.68e-06	4.06e-05	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—AKT1—atherosclerosis	1.68e-06	4.05e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—AGT—atherosclerosis	1.68e-06	4.05e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GPX1—atherosclerosis	1.68e-06	4.05e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—APOE—atherosclerosis	1.65e-06	3.97e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTM1—atherosclerosis	1.64e-06	3.95e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CD36—atherosclerosis	1.63e-06	3.95e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CAV1—atherosclerosis	1.63e-06	3.94e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—APOA1—atherosclerosis	1.63e-06	3.93e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—LPL—atherosclerosis	1.61e-06	3.88e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ALB—atherosclerosis	1.59e-06	3.85e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GPX1—atherosclerosis	1.57e-06	3.78e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—MTHFR—atherosclerosis	1.55e-06	3.74e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CD36—atherosclerosis	1.53e-06	3.69e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—NOS3—atherosclerosis	1.52e-06	3.68e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PPARA—atherosclerosis	1.52e-06	3.67e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PIK3CG—atherosclerosis	1.49e-06	3.59e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—AGT—atherosclerosis	1.47e-06	3.55e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—MTHFR—atherosclerosis	1.45e-06	3.49e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—APOE—atherosclerosis	1.44e-06	3.48e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PPARG—atherosclerosis	1.43e-06	3.46e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CAV1—atherosclerosis	1.43e-06	3.45e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—APOA1—atherosclerosis	1.43e-06	3.44e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PPARA—atherosclerosis	1.42e-06	3.43e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—INS—atherosclerosis	1.41e-06	3.39e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—AKT1—atherosclerosis	1.4e-06	3.37e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—AGT—atherosclerosis	1.37e-06	3.32e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—APOE—atherosclerosis	1.35e-06	3.25e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CAV1—atherosclerosis	1.33e-06	3.22e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—APOA1—atherosclerosis	1.33e-06	3.21e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PIK3CG—atherosclerosis	1.3e-06	3.14e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—STAT3—atherosclerosis	1.3e-06	3.13e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PPARG—atherosclerosis	1.26e-06	3.03e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MAPK3—atherosclerosis	1.24e-06	2.99e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—NOS3—atherosclerosis	1.23e-06	2.98e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—INS—atherosclerosis	1.23e-06	2.97e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PIK3CG—atherosclerosis	1.22e-06	2.93e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—TGFB1—atherosclerosis	1.2e-06	2.9e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PPARG—atherosclerosis	1.17e-06	2.83e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—INS—atherosclerosis	1.15e-06	2.78e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ALB—atherosclerosis	1.13e-06	2.73e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PTGS2—atherosclerosis	1.13e-06	2.72e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—NOS3—atherosclerosis	1.08e-06	2.61e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ALB—atherosclerosis	1.05e-06	2.55e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—NOS3—atherosclerosis	1.01e-06	2.44e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PTGS2—atherosclerosis	9.88e-07	2.38e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PTGS2—atherosclerosis	9.23e-07	2.23e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—IL6—atherosclerosis	9.07e-07	2.19e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—AKT1—atherosclerosis	8.82e-07	2.13e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—AKT1—atherosclerosis	8.36e-07	2.02e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—AKT1—atherosclerosis	7e-07	1.69e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—AKT1—atherosclerosis	5.67e-07	1.37e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—AKT1—atherosclerosis	4.97e-07	1.2e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—AKT1—atherosclerosis	4.64e-07	1.12e-05	CbGpPWpGaD
